Correction to:: Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance (Osteoporosis International, (2019), 10.1007/s00198-019-05181-6)
Publication date
2020-04-01
Authors
Berencsi, K
Sami, A
Ali, M. Sanni
Marinier, K
Deltour, N
Perez-Gutthann, S
Pedersen, L
Rijnbeek, P
Van der Lei, J
Lapi, F
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
taverne
Abstract
The original version of this article, published on 26 November 2019 contained a mistake. An author’s name was misspelled. The correct author name reads as follows: Susana Perez-Gutthann. The original article has been corrected.
Keywords
Taverne, Endocrinology, Diabetes and Metabolism, Published Erratum
Citation
Berencsi, K, Sami, A, Ali, M S, Marinier, K, Deltour, N, Perez-Gutthann, S, Pedersen, L, Rijnbeek, P, Van der Lei, J, Lapi, F, Simonetti, M, Reyes, C, Sturkenboom, M C J M & Prieto-Alhambra, D 2020, 'Correction to: Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance (Osteoporosis International, (2019), 10.1007/s00198-019-05181-6)', Osteoporosis International, vol. 31, no. 4, pp. 799. https://doi.org/10.1007/s00198-020-05314-2